Imaging Bio Share Price (IBAI)

Kane

I find it interesting KS is a board member of Prism where MS used to work and we have collaborated with before.

Thanks

I am sure TB being based in Switzerland is used to keeping an eye out for problems with ice. Fingers crossed he is hopefully.

Let’s see what the interims bring.

•It should show we are due to be making a profit.

•An update on GAM would be good as well.

•If the EAP has been reinstated, why?

•Since phase 1 data released, have we had any more interest in licensing or partnerships?

•Or has a formal valuation been discussed?

•Has there been any interest in other IB products etc

Wishful thinking by me

Thanks

It was the slow sinking feeling here tyke was what I meant!

For context he’s the developer of gallium maltolate and holds many patents on it I believe

Interesting but in the conflict of interest part of the journal entry. Don’t think they mentioned that previously? So hopefully he does want to commercialise it and he gets paid when we get paid for it. Probably a long way off but it makes me feel better knowing he has this agreement with IB

Lawrence R. Bernstein has an agreement with Imaging Biometrics, LLC under which he is a consultant and would receive a royalty on commercial sales of gallium products by Imaging Biometrics.

Conflict of Interest Statement

Jennifer M. Connelly, Casey J. Zoss, Mona M. Al-Gizawiy, Shama P. Mirza, Frederick Adom, and Christopher R. Chitambar: none declared. Lawrence R. Bernstein has an agreement with Imaging Biometrics, LLC under which he is a consultant and would receive a royalty on commercial sales of gallium products by Imaging Biometrics. Kathleen M. Schmainda has ownership and financial interest in Imaging Biometrics, and ownership interest and Board membership in Prism Clinical Imaging Inc.

https://academic.oup.com/noa/article/8/1/vdag154/8703985